{"id":"https://openalex.org/W4408614787","doi":"https://doi.org/10.1158/2767-9764.c.7727264","title":"Data from Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi Nanomedicine","display_name":"Data from Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi Nanomedicine","publication_year":2025,"publication_date":"2025-03-19","ids":{"openalex":"https://openalex.org/W4408614787","doi":"https://doi.org/10.1158/2767-9764.c.7727264"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.c.7727264","doi":"https://doi.org/10.1158/2767-9764.c.7727264","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7727264","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.c.7727264","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023330777","display_name":"Shrusti S. Patel","orcid":"https://orcid.org/0000-0002-9750-4111","observed_orcids":["https://orcid.org/0000-0002-9750-4111"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shrusti S. Patel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9750-4111","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102944784","display_name":"Rebecca S. Cook","orcid":"https://orcid.org/0000-0001-7749-5361","observed_orcids":["https://orcid.org/0000-0001-7749-5361"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca S. Cook","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7749-5361","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050048229","display_name":"Justin Han-Je Lo","orcid":"https://orcid.org/0000-0002-2646-2495","observed_orcids":["https://orcid.org/0000-0002-2646-2495"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justin H. Lo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2646-2495","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056082489","display_name":"Fiona K. Cherry","orcid":"https://orcid.org/0009-0000-4714-0279","observed_orcids":["https://orcid.org/0009-0000-4714-0279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fiona K. Cherry","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-4714-0279","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016143769","display_name":"Ella N. Hoogenboezem","orcid":"https://orcid.org/0000-0001-7697-4336","observed_orcids":["https://orcid.org/0000-0001-7697-4336"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ella N. Hoogenboezem","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7697-4336","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100676757","display_name":"Fang Zhou Yu","orcid":"https://orcid.org/0000-0002-9022-2410","observed_orcids":["https://orcid.org/0000-0002-9022-2410","https://orcid.org/0009-0006-7652-9957"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fang Yu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9022-2410","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079052993","display_name":"Nora Francini","orcid":"https://orcid.org/0000-0001-7681-6442","observed_orcids":["https://orcid.org/0000-0001-7681-6442"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nora Francini","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7681-6442","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021814918","display_name":"Nina T. Cassidy","orcid":"https://orcid.org/0000-0001-9171-8795","observed_orcids":["https://orcid.org/0000-0001-9171-8795"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nina T. Cassidy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9171-8795","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031616038","display_name":"Joshua T. McCune","orcid":"https://orcid.org/0000-0003-4984-176X","observed_orcids":["https://orcid.org/0000-0003-4984-176X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua T. McCune","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4984-176X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093972046","display_name":"Eva F. Gbur","orcid":"https://orcid.org/0009-0006-4440-464X","observed_orcids":["https://orcid.org/0009-0006-4440-464X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eva F. Gbur","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-4440-464X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116461905","display_name":"Lisa Messier","orcid":"https://orcid.org/0009-0006-1092-1841","observed_orcids":["https://orcid.org/0009-0006-1092-1841"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Messier","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-1092-1841","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116461906","display_name":"Thomas A. Dean","orcid":"https://orcid.org/0009-0002-9493-6493","observed_orcids":["https://orcid.org/0009-0002-9493-6493"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas A. Dean","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-9493-6493","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011920497","display_name":"Kalin Wilson","orcid":"https://orcid.org/0009-0004-0368-3174","observed_orcids":["https://orcid.org/0009-0004-0368-3174"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kalin L. Wilson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-0368-3174","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004009810","display_name":"Dana M. Brantley\u2010Sieders","orcid":"https://orcid.org/0000-0002-2751-6547","observed_orcids":["https://orcid.org/0000-0002-2751-6547","https://orcid.org/0000-0001-9873-6339"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dana M. Brantley-Sieders","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2751-6547","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075794128","display_name":"Craig L. Duvall","orcid":"https://orcid.org/0000-0003-3979-0620","observed_orcids":["https://orcid.org/0000-0003-3979-0620"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Craig L. Duvall","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3979-0620","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":1.0},{"id":"https://openalex.org/keywords/mtorc2","display_name":"mTORC2","score":0.8690000176429749},{"id":"https://openalex.org/keywords/rictor","display_name":"Rictor","score":0.9049999713897705},{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.6200000047683716},{"id":"https://openalex.org/keywords/pi3k-mtor-signaling","display_name":"PI3K/mTOR signaling","score":0.8299999833106995},{"id":"https://openalex.org/keywords/pp242","display_name":"PP242","score":0.8410000205039978},{"id":"https://openalex.org/keywords/mtorc1-inhibition","display_name":"mTORC1 inhibition","score":0.8149999976158142},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.8429999947547913},{"id":"https://openalex.org/keywords/tumor-cell-death","display_name":"cancer cell death","score":0.7839999794960022},{"id":"https://openalex.org/keywords/sirna-delivery","display_name":"siRNA delivery","score":0.5669999718666077},{"id":"https://openalex.org/keywords/gene-silencing","display_name":"gene silencing","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7578547596931458},{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.5889734029769897},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5140891671180725},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.458204984664917},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.44853219389915466},{"id":"https://openalex.org/C15083742","wikidata":"https://www.wikidata.org/wiki/Q261659","display_name":"Nanomedicine","level":3,"score":0.4431918263435364},{"id":"https://openalex.org/C107846503","wikidata":"https://www.wikidata.org/wiki/Q14876061","display_name":"mTORC2","level":5,"score":0.4307161867618561},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36462244391441345},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34539371728897095},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26392701268196106},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2398035228252411},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.14959979057312012},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.12590542435646057},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.12587794661521912},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11376792192459106},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.10283246636390686},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.09937441349029541},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.08682340383529663},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.07588493824005127},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.c.7727264","doi":"https://doi.org/10.1158/2767-9764.c.7727264","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7727264","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.c.7727264","doi":"https://doi.org/10.1158/2767-9764.c.7727264","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7727264","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408052027","https://openalex.org/W4362541101","https://openalex.org/W4408614352","https://openalex.org/W4408614085","https://openalex.org/W4408614165","https://openalex.org/W4361234588","https://openalex.org/W2792383110","https://openalex.org/W4408614245","https://openalex.org/W2321491799","https://openalex.org/W4408591693"],"abstract_inverted_index":{"Abstract":[0],"Alterations":[1],"in":[2,10,51,63,119,139,141,156,159,169,203,218,223],"the":[3,38,185],"PI3K/mTOR":[4],"signaling":[5,46,112,166],"pathway":[6],"are":[7],"often":[8],"seen":[9],"triple-negative":[11],"breast":[12,16,53],"cancers":[13],"(TNBC),":[14],"a":[15],"cancer":[17,54],"subtype":[18],"characterized":[19],"by":[20,87],"limited":[21],"molecularly":[22],"targeted":[23],"treatment":[24,202],"options":[25],"and":[26,47,73,78,126,152,167,201],"poorer":[27],"patient":[28,49],"outcomes.":[29],"We":[30,128,206],"report":[31],"that":[32,212],"gene":[33,154],"amplification":[34],"or":[35,110],"overexpression":[36],"of":[37,80,122,136,145,188],"mTORC2-required":[39],"cofactor":[40],"RICTOR":[41,137,161,192],"correlated":[42],"with":[43,214],"increased":[44],"mTORC2":[45,61,116,165],"worse":[48],"outcomes":[50],"clinical":[52],"expression":[55],"datasets,":[56],"supporting":[57],"studies":[58],"examining":[59],"selective":[60],"inhibition":[62,86,121,200],"TNBC.":[64,204],"The":[65],"mTOR":[66],"kinase":[67],"inhibitor":[68],"PP242":[69,88],"blocks":[70],"both":[71],"mTORC1":[72,85,111],"mTORC2,":[74],"which":[75],"decreases":[76],"growth":[77,125,168],"survival":[79],"RICTOR-amplified":[81],"TNBC":[82,157,171,177],"cells.":[83],"However,":[84],"causes":[89],"resurgent":[90],"PI3K":[91,109],"signaling,":[92,117],"limiting":[93],"its":[94],"therapeutic":[95,134,191],"impact.":[96],"In":[97],"contrast,":[98],"knockdown":[99],"using":[100],"siRNA":[101,150],"designed":[102],"against":[103],"Rictor":[104],"(siRictor)":[105],"did":[106],"not":[107],"increase":[108],"but":[113],"potently":[114],"blocked":[115,163],"resulting":[118],"robust":[120],"tumor":[123,164,178,220],"cell":[124,221],"survival.":[127],"developed":[129],"siRictor-loaded":[130],"nanoparticles":[131],"to":[132,180,216],"enable":[133],"testing":[135],"silencing":[138,155,162,193],"TNBCs":[140],"vivo.":[142,160],"Intravenous":[143],"delivery":[144],"this":[146],"mTORC2-selective":[147,199],"nanomedicine":[148,211],"achieved":[149],"accumulation":[151],"on-target":[153],"tumors":[158],"multiple":[170],"mouse":[172],"models":[173],"while":[174],"also":[175],"improving":[176],"response":[179],"chemotherapy.":[181],"These":[182],"findings":[183],"support":[184],"further":[186],"development":[187],"technologies":[189],"for":[190,198],"as":[194],"an":[195,208],"effective":[196],"approach":[197],"Significance:":[205],"identified":[207],"mTORC2/Rictor-directed":[209],"RNAi":[210],"cooperates":[213],"chemotherapy":[215],"enhance":[217],"vivo":[219],"killing":[222],"PI3K-active":[224],"TNBCs.":[225]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-03-20T00:00:00"}
